Squarepoint’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.16M Buy
102,642
+44,986
+78% +$1.82M ﹤0.01% 854
2025
Q1
$2.96M Buy
57,656
+51,652
+860% +$2.65M ﹤0.01% 977
2024
Q4
$332K Sell
6,004
-51,329
-90% -$2.84M ﹤0.01% 2138
2024
Q3
$1.89M Buy
+57,333
New +$1.89M ﹤0.01% 1153
2024
Q2
Sell
-33,867
Closed -$1.23M 2966
2024
Q1
$1.23M Buy
+33,867
New +$1.23M ﹤0.01% 1252
2023
Q4
Sell
-19,344
Closed -$344K 2959
2023
Q3
$344K Buy
19,344
+9,303
+93% +$165K ﹤0.01% 1847
2023
Q2
$181K Sell
10,041
-3,896
-28% -$70.4K ﹤0.01% 2106
2023
Q1
$175K Buy
+13,937
New +$175K ﹤0.01% 1910